Charles Herbaux (C Herbaux)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Multiple Myeloma

Hodgkin Lymphoma

Histone Deacetylase

Stem Cell Transplantation

Top Venues

British journal of haematology

Healthcare (Basel, Switzerland)

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Vincent Camus, Roch Houot, Gabriel Brisou, Benoît Tessoulin, Sebastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Judith Trotman, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérôme Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Outcome of large B-cell lymphoma patients treated with tafasitamab plus lenalidomide either before or after CAR-T-cells. Blood advances (2024)
Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roosweil, Inès Laribi de Materre, Xavier Roussel, Morgane Nudel, Sabine Tricot, Jehan Dupuis, Ronan LE Calloch, Benoit Bareau, Véronique Leblond
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO). British journal of haematology (2024)
Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roosweil, Inès Laribi de Materre, Xavier Roussel, Morgane Nudel, Sabine Tricot, Jehan Dupuis, Ronan LE Calloch, Benoit Bareau, Véronique Leblond
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO). British journal of haematology 204 (6) (2024)
Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roosweil, Inès Laribi de Materre, Xavier Roussel, Morgane Nudel, Sabine Tricot, Jehan Dupuis, Ronan LE Calloch, Benoit Bareau, Véronique Leblond
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO). British journal of haematology 204 (6) (2024)
Tony Marchand, Cédric Pastoret, Gandhi Damaj, Angélique Lebouvier, Charles Herbaux, Aline Moignet, Miguel Pavlosky, Astrid Pavlosky, Anaise Blouet, Martin Eloit, Vincent Launay, Pierre Lebreton, Aspassia Stamatoullas, Christer Nilsson, Marlène Ochmann, Juliette Prola, Thierry Lamy
Efficacy of ruxolitinib in the treatment of relapsed/refractory large granular lymphocytic leukaemia. British journal of haematology (2024)
Amira Marouf, N Molinari, David Sibon, A S Cottereau, S Kanoun, C Antoine, P E Debureaux, D Cavalieri, L M Fornecker, R O Casasnovas, Charles Herbaux, S Amorim, Cédric Rossi, D Bouscary, P Brice, Hervé Ghesquières, J Tamburini, Benedicte Deau
Tandem haematopoietic stem cell transplantation versus single cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA. British journal of haematology (2023)
Guillaume Cartron, Emmanuel Bachy, Herve Tilly, Nicolas Daguindau, Gian-Matteo Pica, Fontanet Bijou, Christiane Mounier, Aline Clavert, Gandhi Laurent Damaj, Borhane Slama, René-Olivier Casasnovas, Houot Roch, Krimo Bouabdallah, David Sibon, Olivier Fitoussi, Nadine Morineau, Charles Herbaux, Thomas Gastinne, Luc-Matthieu Fornecker, Corinne Haioun, Vincent Launay, Carla Araujo, Omar Benbrahim, Laurence Sanhes, Remy Gressin, Hugo Gonzalez, Judith Trotman, David Ternant, Luc Xerri, Karin Tarte, Delphine Pranger
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Djamila Chemlal, Emmanuel Varlet, Amelie Machura, Sara Ovejero, Guilhem Requirand, Nicolas Robert, Guillaume Cartron, Elina Alaterre, Caroline Bret, Laure Vincent, Charles Herbaux, Giacomo Cavalli, Angélique Bruyer, Hugues De Boussac, Jérôme Moreaux
EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma. Leukemia (2023)
Sarah Bonnet, Serge Carillo, Baptiste Legrand, Barbara Burroni, Thierry Lavabre-Bertrand, Guilhem Requirand, Nicolas Robert, Lea Fornero, Ahmed Al Mansoori, Jérôme Moreaux, Guillaume Cartron, Ludovic Gabellier, Charles Herbaux
Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3. European journal of haematology (2023)
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Judith Trotman, Catherine Thieblemont, Roch Houot
Non-Relapse Mortality after CAR T-Cell therapy for Large B-Cell Lymphoma: A LYSA Study from the DESCAR-T Registry. Blood advances (2023)
Sylvain Lamure, Charles Herbaux
Anti-PD-1 therapy can possibly reverse CAR T cells exhaustion in DLBCL. British journal of haematology (2023)
Charles Herbaux, Aurélie Dupré, Wendy Rénier, Ludovic Gabellier, Emmanuel Chazard, Philippe Lambert, Vincent Sobanski, Didier Gosset, Dominique Lacroix, Patrick Truffert
Formative Assessment of Diagnostic Testing in Family Medicine with Comprehensive MCQ Followed by Certainty-Based Mark. Healthcare (Basel, Switzerland) 10 (8) (2022)
Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Béatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, René-Olivier Casasnovas, Delphine Nollet, Damien Roosweil, Sylvie Chevret, Véronique Leblond
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia. Blood advances 5 (9) (2021)
Elina Alaterre, Veronika Vikova, Alboukadel Kassambara, Angélique Bruyer, Nicolas Robert, Guilhem Requirand, Caroline Bret, Charles Herbaux, Laure Vincent, Guillaume Cartron, Olivier Elemento, Jérôme Moreaux
RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma. Journal of personalized medicine 11 (10) (2021)
Sylvain Lamure, François Van Laethem, Delphine De Verbizier, Claire Lozano, Eve Gehlkopf, Jean Jacques Tudesq, Chris Serrand, Mehdi Benzaoui, Tarik Kanouni, Adeline Quintard, John de Vos, Emmanuelle Tchernonog, Laura Platon, Xavier Ayrignac, Patrice Ceballos, Anne Sirvent, Mickael François, Hanane Guedon, Philippe Quittet, Cedric Mongellaz, Aurélie Conte, Charles Herbaux, Caroline Bret, Naomi Taylor, Valérie Dardalhon, Guillaume Cartron
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy. Cancers 13 (17) (2021)
Charles Herbaux, Christoph Kornauth, Stéphanie Poulain, Stephen J F Chong, Mary C Collins, Rebecca Valentin, Liam Hackett, Olivier Tournilhac, François Lemonnier, Jehan Dupuis, Adrien Daniel, Cecile Tomowiak, Kamel Laribi, Richard Greil, Damien Roosweil, Cédric Rossi, Eric Van Den Neste, Cecile Leyronnas, Fatiha Merabet, Jean Valère Malfuson, Mourad Tiab, Loïc Ysebaert, Samuel Ng, Judith Trotman, Philipp B Staber, Matthew S Davids
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia. Blood 137 (25) (2021)